Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alpaslan Tasdogan

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Dermatologie (Heidelberg, Germany)|October 15, 2024
Alpaslan Tasdogan, Joachim Dissemond
The EMBO Journal|May 12, 2025
Approaches to stable isotope tracing and in vivo metabolomics in the cancer clinicBrandon Faubert, Alpaslan Tasdogan
Dermatologie (Heidelberg, Germany)|June 27, 2024
[Multilocular pyoderma gangrenosum from levamisole adulterated cocaine]Alpaslan Tasdogan, Joachim Dissemond
Dermatologie (Heidelberg, Germany)|July 19, 2024
Alpaslan Tasdogan, Joachim Dissemond
Dermatologie (Heidelberg, Germany)|June 23, 2025
[Pyoderma gangrenosum: pathogenesis, diagnosis, and treatment]Joachim Dissemond, Maurice Moelleken, Alpaslan Tasdogan
JAAD Case Reports|January 21, 2025
Topical ruxolitinib for treatment-induced vitiligo in a patient with metastatic melanomaAlpaslan Tasdogan, Dirk Schadendorf, Selma Ugurel
Zeitschrift Fur Gerontologie Und Geriatrie|August 29, 2023
[Eczema of wound surroundings : Genesis, diagnostics and treatment]Alpaslan Tasdogan, Maurice Moelleken, Joachim Dissemond
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 29, 2026
Cutaneous leukocytoclastic vasculitis as acute hemorrhagic edema in a 71-year-old patientAlpaslan Tasdogan, Eva Hadaschik, Joachim Dissemond
Cell Cycle (Georgetown, Tex.)|March 31, 2017
The IFN-1 > BID > ROS pathway: Linking DNA damage with HSPC malfunctionAtan Gross, Alpaslan Tasdogan, Hans Joerg Fehling
Trends in Cancer|September 27, 2020
Mitochondrial DNA Haplotypes as Genetic Modifiers of CancerAlpaslan Tasdogan, David G McFadden, Prashant Mishra
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Dermatologie (Heidelberg, Germany)|October 15, 2024
Alpaslan Tasdogan, Joachim Dissemond
The EMBO Journal|May 12, 2025
Approaches to stable isotope tracing and in vivo metabolomics in the cancer clinicBrandon Faubert, Alpaslan Tasdogan
Dermatologie (Heidelberg, Germany)|June 27, 2024
[Multilocular pyoderma gangrenosum from levamisole adulterated cocaine]Alpaslan Tasdogan, Joachim Dissemond
Dermatologie (Heidelberg, Germany)|July 19, 2024
Alpaslan Tasdogan, Joachim Dissemond
Dermatologie (Heidelberg, Germany)|June 23, 2025
[Pyoderma gangrenosum: pathogenesis, diagnosis, and treatment]Joachim Dissemond, Maurice Moelleken, Alpaslan Tasdogan
JAAD Case Reports|January 21, 2025
Topical ruxolitinib for treatment-induced vitiligo in a patient with metastatic melanomaAlpaslan Tasdogan, Dirk Schadendorf, Selma Ugurel
Zeitschrift Fur Gerontologie Und Geriatrie|August 29, 2023
[Eczema of wound surroundings : Genesis, diagnostics and treatment]Alpaslan Tasdogan, Maurice Moelleken, Joachim Dissemond
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 29, 2026
Cutaneous leukocytoclastic vasculitis as acute hemorrhagic edema in a 71-year-old patientAlpaslan Tasdogan, Eva Hadaschik, Joachim Dissemond
Cell Cycle (Georgetown, Tex.)|March 31, 2017
The IFN-1 > BID > ROS pathway: Linking DNA damage with HSPC malfunctionAtan Gross, Alpaslan Tasdogan, Hans Joerg Fehling
Trends in Cancer|September 27, 2020
Mitochondrial DNA Haplotypes as Genetic Modifiers of CancerAlpaslan Tasdogan, David G McFadden, Prashant Mishra
Pageof 10